SGLT2i, Hepatic Glucose Production, and SNS

NCT07053293 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Empagliflozin 25 MG

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]